Enhancing India's Health Preparedness System: Addressing Challenges and Recommendations

Strategic Insights -

The COVID-19 pandemic highlighted significant gaps in India's institutional and legal framework for handling serious biological threats, revealing systemic flaws in existing frameworks that enable surveillance, readiness, and responsiveness. The country's ability to identify and respond to pathogens depends on technological breakthroughs in a defined framework, an innovation-based ecosystem, and sustained international collaboration. India has made strides in domestic innovation, public-private partnerships, and strengthened surveillance mechanisms, but challenges persist in standardising emergency regulatory approvals, accommodating global supply chain shocks, predicting public health demands, and establishing long-lasting connections between research institutions and industry partners.

Key Takeaways:

  • The Epidemic Diseases Act of 1897 and the National Disaster Management Act of 2005 lack a thorough public health and clinical management framework, and were not created to address the complexity of a pandemic in the twenty-first century.
  • India has seen a rise in domestic innovation, including the rapid development of diagnostic kits, personal protective equipment (PPE), and domestic vaccines such as ZyCoV-D and COVAXIN.
  • Public-private partnerships (PPPs) have been established, but challenges persist in standardising emergency regulatory approvals, accommodating global supply chain shocks, predicting public health demands, and establishing long-lasting connections between research institutions and industry partners.
  • Surveillance mechanisms were strengthened, with the expansion of testing infrastructure, genomic surveillance through INSACOG, and digital tools like Aarogya Setu and COWIN, but surveillance systems operated in silos, often lacking interoperability and comprehensive data integration.
  • The private healthcare sector, catering to 60% of the population, remains a lacuna in healthcare delivery.
  • The "One Health" approach remains under-resourced and fragmented, with recurrent outbreaks of zoonotic diseases such as Nipah Virus (NiV) underscore the urgency of integrated ecosystem health monitoring and preventive interventions.

Recommended Solutions:

  • India needs to institutionalise international collaborations to meet transboundary health threats, with joint exercises, common data repositories, and cross-border early warning systems enhancing pandemic response capacity.
  • A National Biosecurity & Biosafety Network should be established to address accidental and intentional biological threats, ensuring that all laboratories dealing with pathogens follow standardised safety procedures.
  • A dedicated PPP framework should be formalised to bridge research institutions and the private sector, enabling rapid technology transfer, emergency regulatory approvals, and standardised production protocols.
  • The One Health approach should be integrated and implemented, with community-driven initiatives (bottom-up) and national policies (top-down) being engaged to address zoonotic diseases.
  • Predictive models should be developed to forecast outbreaks using integrated data, with an early warning system (EWS) supported by such predictive models drastically reducing morbidity and mortality.
  • An integrated health data platform should be established, integrating genomic, immunological, and serological information at local, state, and national levels.
  • A Public Health Emergency Management Act (PHEMA) should be enacted to define the scope of emergency powers, designate responsibilities across agencies, enable rapid resource mobilisation, and decentralise implementation.

Statistics:

  • The private healthcare sector caters to 60% of the population.
  • India has seen a rise in domestic innovation, with the rapid development of diagnostic kits, PPE, and domestic vaccines.
  • INSACOG, the Indian SARS-CoV-2 Genomics Consortium, conducted genomic surveillance.
  • 60% of the population relies on the private healthcare sector.

Sources:

  • MM Activ Sci-Tech Communications Pvt. Ltd., distributed by Contify.com (copyright 2025)
  • National Disaster Management Act of 2005
  • Epidemic Diseases Act of 1897
  • INSACOG: Indian SARS-CoV-2 Genomics Consortium
  • IDSP: Integrated Disease Surveillance Programme
  • ICMR: Indian Council of Medical Research
  • DBT: Department of Biotechnology
  • MoHFW: Ministry of Health and Family Welfare
  • NITI Aayog: National Institution for Transforming India

Note: The statistics and references are based on the provided text, and no additional information or embellishments have been added.